ストックスクリーナーアプリを入手
16.46
5.18%
0.81
アフターアワーズ：
16.61
0.15
+0.91%
前日終値:
$15.65
開ける：
$16.2
24時間の取引高:
3.68M
Relative Volume:
1.37
時価総額：
$1.88B
収益：
$631.73M
当期純損益:
$-239.78M
株価収益率:
-8.1485
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
+0.67%
1か月 パフォーマンス:
+25.27%
6か月 パフォーマンス:
+81.28%
1年 パフォーマンス:
+23.57%
1日の値動き範囲:
$16.11
$17.16
1週間の範囲:
$15.12
$17.16
52週間の値動き範囲:
$6.78
$17.70
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
16.46 | 1.98B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
270.50 | 44.75B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
65.69 | 12.29B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
100.73 | 8.92B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
46.42 | 9.04B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
34.79 | 6.66B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-11 | 開始されました | Piper Sandler | Neutral |
| 2025-02-13 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
Spatial Biology Market Analysis and Forecast, 2025-2035: - GlobeNewswire
Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum - Yahoo Finance
How 10x Genomics Inc. (1KJ) stock trades pre earnings2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
Is 10x Genomics Inc. stock a buy before product launchesJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
10x Genomics (Nasdaq: TXG) Xenium Powers ASTRA Atlas of 2,000 Asia-Pacific Tumor Samples - Stock Titan
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
10x Genomics Announces Chief Legal Officer Retirement - MSN
10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st
10x Genomics, Inc. Announces Executive Changes, Effective January 1, 2026 - MarketScreener
10X Genomics Stock Soars 17.31%, Hits Intraday High of $15.26 - Markets Mojo
10x Genomics Inc Class A Earnings and Revenue – HAM:1KJ - TradingView
How 10x Genomics Inc. (1KJ) stock valuation compares with sectorChart Signals & Safe Entry Point Alerts - newser.com
Why 10x Genomics Inc. (1KJ) stock attracts wealthy investorsSell Signal & Verified Stock Trade Ideas - newser.com
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - Eastern Progress
10x Genomics (TXG): Assessing Valuation After Strong Earnings, Upbeat Forecast and New Product Launch - Yahoo Finance
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
10x Genomics to Participate in the Wolfe Research Healthcare Con - GuruFocus
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Insider Monkey
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
Is 10x Genomics Inc. stock ready for a breakoutWeekly Market Summary & AI Enhanced Trading Signals - newser.com
Can a trend reversal in 10x Genomics Inc. lead to recovery2025 Volume Leaders & Real-Time Volume Analysis - newser.com
10x Genomics stock hits 52-week high at 17.26 USD - Investing.com
10x Genomics, Inc.'s (NASDAQ:TXG) 33% Price Boost Is Out Of Tune With Revenues - 富途牛牛
Research Alert: CFRA Keeps Hold Rating On Shares Of 10x Genomics, Inc. - 富途牛牛
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Eledon Pharmaceuticals (ELDN) and AMN Healthcare Services (AMN) - The Globe and Mail
10x Genomics (TXG): How Fresh Results and New Guidance Are Shaping Its Valuation - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
TXG: Canaccord Genuity Raises Price Target for 10x Genomics to $19 | TXG Stock News - GuruFocus
GUIDANCE: (TXG) 10x Genomics, Inc. Expects Q4 Revenue Range $154.0M$158.0M - 富途牛牛
10x Genomics, Inc. SEC 10-Q Report - TradingView
10x Genomics: Q3 Earnings Snapshot - CT Insider
Is 10x Genomics Inc. stock supported by strong fundamentalsPortfolio Risk Report & Safe Entry Trade Signal Reports - newser.com
10x Genomics Inc (TXG) Q3 2025 Earnings Call Highlights: Navigat - GuruFocus
Transcript : 10x Genomics, Inc., Q3 2025 Earnings Call, Nov 06, 2025 - MarketScreener
Is 10x Genomics Inc. (1KJ) stock undervalued historicallyQuarterly Portfolio Report & Proven Capital Preservation Methods - newser.com
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - sharewise.com
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
[10-Q] 10x Genomics, Inc. Quarterly Earnings Report | TXG SEC FilingForm 10-Q - Stock Titan
10X Genomics Q3 revenue beats expectations, net loss narrows - MarketScreener
10x Genomics Inc (TXG) Q3 2025 Earnings: EPS of -$0.22 Beats Est - GuruFocus
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics Reports Third Quarter 2025 Financial Results - WV News
(TXG) 10x Genomics, Inc. Expects Q4 Revenue Range $154.0M$158.0M - MarketScreener
Earnings Flash (TXG) 10x Genomics, Inc. Reports Q3 Revenue $149.0M, vs. FactSet Est of $142.5M - MarketScreener
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.03%
大文字化:
|
ボリューム (24 時間):